Drug companies continued to lead the list of the most-searched stocks on TheStreet.com Friday.

Dendreon ( DNDN) is first on the list after the company presented positive results for its prostate cancer drug, Provenge. The company will seek FDA approval for its cancer "vaccine" in the fourth quarter.

Next is Cell Therapeutics ( CTIC), which develops and commercializes cancer-treatment products. This penny stock was soaring more than 20%.

Sequenom ( SQNM) stayed on the list after the company said that data for its prenatal Down syndrome genetic test was unreliable. The stock was bouncing back 13% today after Thursday's massive selloff.

The last biotech name on the list is Novavax ( NVAX - Get Report), which owns technology for making vaccines. Stock was selling off today as swine flu fears receded.

Let's jump to banks.

Citigroup ( C - Get Report) and Bank of America ( BAC - Get Report) make the list after the Federal Reserve said it may delay the results of the stress tests on the biggest national banks.

Citi also said Friday that it will sell its Nikko Cordial unit to Sumitomo Mitsui for $5.6 billion.

General Electric ( GE - Get Report) is up. Cramer is buying this stock as an industrial play for his Action Alerts PLUS charitable trust despite concerns over its GE Capital finance unit. To see how Cramer is buying this stock, email for a free trial now!

Next is Ford ( F - Get Report). Auto sales dropped 31.5% in April, but the car company continued to steal market share from its competitors, General Motors ( GM) and Chrysler.

Energy bigwig BP ( BP) also makes the list. BP's earnings beat analysts' estimates even though its profit fell 64%.

Apple ( AAPL) rounds out the top-10 list after Cramer gave it a thumbs up on Mad Money. He praised Apple for strong sales, low costs and top-line growth.

Alix joined TheStreet.com TV in February 2007. Previously, she held positions in film and theater production, management, and legal administration. Alix has a degree in communications and theater from Northwestern University.